Deuterated therapeutics: Forensic toxicology consequences

Journal of Analytical Toxicology

Volumn 33, Issue 7, 2009, Pages 393-394

  Kerrigan, Sarah ^a  

^a SAM HOUSTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; CYTOCHROME P450 2D6; DEUTERATED ANALOGUE; DEUTERIUM; DEXTROMETHORPHAN; DRUG ANALOG; DULOXETINE; FLUOXETINE; HYDROCODONE; IBUPROFEN; MOSAPRIDE CITRATE; OXYCODONE; PAROXETINE; RIMONABANT; SD 254; SERTRALINE; UNCLASSIFIED DRUG; VENLAFAXINE; ZOLPIDEM;

CHEMICAL MODIFICATION; CLINICAL TRIAL; DRUG COST; DRUG DETERMINATION; DRUG METABOLISM; DRUG SAFETY; FORENSIC TOXICOLOGY; HALF LIFE TIME; HUMAN; LETTER; PATENT; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

EID: 70349301427     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/33.7.393     Document Type: Letter

References (8)

1. K. Sanderson. Big interest in heavy drugs. Nature 458: 269 (2009).
2. Auspex Pharmaceuticals. http://www.auspexhpharma.com/About-Us.html. June 16, 2009.
3. http://www.auspexpharma.com/Product-Pipeline.html. June 16, 2009.
4. Concert Pharmaceuticals, Inc. http://www.concertpharma.com/about/index. html. June 16, 2009.
5. Concert Pharmaceuticals in Potential $1B GSK Deal. June 2009. http://www.masshightech.com/stories/2009/06/01/daily1 1-Concert-Pharmaceuticals- in-potential-1B-GSK-deal.html. June 16, 2009.
6. GSK and Concert Pharmaceuticals form alliance to develop novel deuterium-modified drugs. GlaxoSmithKline Press Release, June 2009. http://www.gsk.com/media/pressreleases/2009/2009-pressrelease-10057.htm. June 16, 2009.
7. SOFT/AAFS Forensic Toxicology Laboratory Guidelines, 2006 Version. Available at www.soft-tox.org.
8. K. Sanderson. Forensic labs warn of deuterated drug threat. Nature 458: 817 (2009).